What is Azenta's impairment charges?

Azenta (AZTA) reported impairment charges of $149.08M in Q1 2026.

What does impairment charges mean?

Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.

Azenta AZTA Impairment Charges

Impairment Charges at other companies

DanaherDHR

$0-100%

Maravai LifeSciences Holdings, Inc.MRVI

$605K-95.1%

GeneDx HoldingsWGS

$31.29M—

10x Genomics, Inc.TXG

$313.25K—

RevvityRVTY

$1.2M-79.0%

Agilent TechnologiesA

$15M—

Other financials

Income statement

See full

Revenue$144.8M+1.0%

Gross profit$62.0M-1.2%

Operating income-$165.8M-811%

Net income-$160.8M-237%

EPS (diluted)-$3.49-236%

Balance sheet

See full

Cash & equivalents$125.2M—

Total debt$55.7M—

Total equity$1.6B-8.3%

Total assets$1.9B—

Cash flow

See full

Operating cash flow$13.5M-6.2%

CapEx$7.4M-0.1%

Free cash flow$6.1M-12.7%

Valuation

See full

Market cap$1.1B-19.0%

Enterprise value$1.03B—

P/S1.8×-0.3×

Profitability

See full

Gross margin40%-1.0pp

Operating margin-31.6%-59.7pp

Net margin-29.1%-80.7pp

FCF margin8.6%—

Returns & leverage

See full

Return on equity-10.7%-22.4pp

Debt / equity0×—

Current ratio2.8×—

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAndIntangibleAssetImpairment.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Azenta's impairment charges?: Azenta (AZTA) reported impairment charges of $149.08M in Q1 2026.
What does impairment charges mean?: Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.